BLACK DIAMOND THERAPEUTICS I (BDTX)

US09203E1055 - Common Stock

4.87  -0.37 (-7.06%)

After market: 5.01 +0.14 (+2.87%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

 MRQ
(2024-3-31)		 2023
(2023-12-31)		 2022
(2022-12-31)		 2021
(2021-12-31)		 2020
(2020-12-31)
ASSETS
Current Assets
Cash Equivalents
25.42M56.22M34.30M65.80M34.60M
Marketable Securities
89.78M75.18M88.50M144.00M280.50M
Other Current Assets
3.61M2.63M4.90M5.90M4.50M
Total Current Assets
118.81M134.03M127.70M215.70M319.60M
 
Non-Current Assets
PPE Net
22.90M23.71M27.40M30.70M8.80M
Other Non-Current Assets
819.00K823.00K1.20M1.20M1.30M
Total Non-Current Assets
23.71M24.53M28.60M32.00M10.10M
 
TOTAL ASSETS
142.52M158.57M156.30M247.70M329.70M
 
LIABILITIES
Current Liabilities
Short Term Debt
0.000.000.000.000.00
Accrued Expenses
15.68M17.32M13.40M19.50M11.70M
Accounts Payable
1.18M2.32M1.90M4.10M2.50M
Other Current Liabilities
N/AN/AN/AN/AN/A
Total Current Liabilities
16.85M19.65M15.30M23.60M14.20M
 
Non-Current Liabilities
Long Term Debt
0.000.000.000.000.00
Other Non-Current Liabilities
21.36M22.18M25.30M28.10M7.70M
Total Non-Current Liabilities
21.36M22.18M25.30M28.20M7.70M
 
TOTAL LIABILITIES
38.22M41.83M40.60M51.80M21.90M
 
SHAREHOLDERS' EQUITY
Retained Earnings
-435.66M-417.43M-335.00M-243.80M-118.20M
Additional Paid In Capital
540.05M534.19M452.50M440.10M425.40M
Common Shares
7.00K7.00K0.000.000.00
Other Shareholders' Equity
-95.00KN/AN/A-400.00K600.00K
Shares Outstanding
52.53M51.65M36.40M36.20M36.10M
Tangible Book Value per Share
1.992.263.185.418.53
Total Shareholders' Equity
104.31M116.74M115.70M195.90M307.80M
 
TOTAL LIABILITIES AND EQUITY
142.52M158.57M156.30M247.70M329.70M
 
Statistics
Current Ratio
7.056.828.359.1422.51
Return On Assets (ROA)
-55.99%-51.99%-58.33%-50.71%-20.40%
Return On Equity (ROE)
-76.50%-70.62%-78.80%-64.11%-21.85%

All data in USD

Charts